Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The FDA has granted orphan drug designation to the investigational remedy BA-101 for the remedy of sufferers with glioblastoma.The U.S. Meals and Drug...
Ifinatamab deruxtecan (I-DXd) at 12 mg/kg could provide significant advantages for sufferers with beforehand handled extensive-stage small cell lung most cancers, in keeping...
Individuals with EGFR+ NSCLC whose illness unfold exterior the mind after therapy with Tagrisso lived longer once they saved taking Tagrisso together with...
